Debt-to-equity of OnKure Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
OnKure Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • OnKure Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 10%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

OnKure Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10% +14% 30 Sep 2025
Q2 2025 23% +36% 30 Jun 2025
Q1 2025 -40% -163% -133% 31 Mar 2025
Q4 2024 -7.5% -29% -135% 31 Dec 2024
Q3 2024 -3.5% -22% -119% 30 Sep 2024
Q2 2024 -13% -29% -177% 30 Jun 2024
Q1 2024 122% +108% +725% 31 Mar 2024
Q4 2023 22% +10% +85% 31 Dec 2023
Q3 2023 18% +11% +163% 30 Sep 2023
Q2 2023 17% +11% +191% 30 Jun 2023
Q1 2023 15% +10% +241% 31 Mar 2023
Q4 2022 12% +6.7% +133% 31 Dec 2022
Q3 2022 6.9% -1.3% -16% 30 Sep 2022
Q2 2022 5.7% 30 Jun 2022
Q1 2022 4.4% 31 Mar 2022
Q4 2021 5% 31 Dec 2021
Q3 2021 8.2% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.